tykhr
sign in
free sign up
Kiniksa Pharmaceuticals Ltd
Drug Manufacturers - Specialty & Generic
Healthcare
KNSA
77.94 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
35.89
52 week high
37.10
high
36.41
52 week low
0.00
low
35.89
growth
41.69 %
previous Close
36.08
P/E ratio
market cap
2.63 B
div yield
0
usd
Jun 2025
qoq
revenue
157 M
13.80 %
net incoming
17.83 M
108.83 %
eps
0.00 %
109.09 %
eps surprise
21.05 %
net profit margin
11.37 %
5.00 %
operating incoming
20.16 M
51.90 %
net change in cash
34.91 M
231.97 %
cash on hand
192 M
22.21 %
cost of revenue
71.02 M
15.19 %
top